Clinical Trial Update: AI Models vs Non-Invasive Fibrosis Scores in MAFLD Diagnosis

View source ↗

Summary

A completed clinical trial comparing artificial intelligence models against non-invasive fibrosis scores for diagnosing metabolic dysfunction-associated fatty l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease

Snippet

Sponsor: Tanta University | Conditions: MAFLD, AI (Artificial Intelligence) | Status: COMPLETED